✦ LIBER ✦

2 The Hungarian experience with gemcitabine-cisplatin as first-line treatment of advanced non-small cell lung cancer: Focus on safety profile

✍ Scribed by Balikó, Zoltán; Sárosi, Veronika

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

8 Gemcitabine-cisplatin as first-line tr

✍ Kovács, Gábor; Ostoros, Gyula; Gergely-Farmos, Erzsébet; Magyar, Pál; Szondy, Kl 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

A randomized phase II study of recombina

✍ Xin Zhao, Kai Mei, Xiaohong Cai, Jing Chen, Jingrui Yu, Chengya Zhou, Qiu Li 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 136 KB

Comparison of docetaxel/cisplatin to doc

✍ Georgoulias, V.; Samonis, G.; Papadakis, E.; Alexopoulos, A.; Tsiafaki, X.; Rapt 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 75 KB

An indirect comparison of bevacizumab pl

✍ John Wen-Cheng CHANG; Sumitra THONGPRASERT; Elaine WRIGHT; Kenneth TSANG; Heung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

Randomised multicenter phase II study of

✍ Novello, Silvia; Falcone, Alfredo; Crinò, Lucio; Rinaldi, Massimo; Nardi, Mario; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 360 KB

PCN33 Indirect Analysis of the Efficacy

✍ Ramirez Gamez, J.; Cruz Cadena, A.; Davey, P.; Rajan, N.; Barraclough, H.; Orlan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB